BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, April 20, 2025
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Home
»
Topics
» BioWorld Science, Cancer
BioWorld Science, Cancer
RSS
Receptagen discovers vitamin B12 uptake inhibitor
May 10, 1996
New cytokine purified by Japanese investigators
May 10, 1996
Compassion use trial of PN 27.1 in prostate cancer patients underway
May 10, 1996
Hybridon will file IND for antisense PKA down-regulator
May 10, 1996
SunPharm to test DEHOP in cancer patients
May 10, 1996
Oncolysin B effective in tumor models in mice; phase II trials underway
May 10, 1996
Agouron reports phase II data for Thymitaq
May 3, 1996
Hybridon reports oligonucleotide MDR inhibitors
May 3, 1996
Vertex dedicates significant efforts to MDR-reversing agents
May 3, 1996
Receptagen will develop vitamin B12 uptake inhibitors
May 3, 1996
Previous
1
2
…
3516
3517
3518
3519
3520
3521
3522
3523
3524
…
3529
3530
Next